Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
3/20/2024 | Outperform → Perform | Oppenheimer | ||
2/9/2024 | Hold → Buy | Canaccord Genuity | ||
5/10/2023 | $4.25 → $4.75 | Hold → Buy | Craig Hallum | |
4/4/2023 | Underperform → Mkt Perform | Bernstein | ||
11/8/2022 | $5.00 → $2.00 | Buy → Hold | Truist | |
11/2/2022 | $3.00 | Mkt Perform | Bernstein | |
11/2/2022 | $1.50 | Underperform | Bernstein | |
10/26/2022 | Sell → Hold | Canaccord Genuity |
Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB, Sept. 17, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology. Auto-flowering is a genetic characteristic that automatically transitions the plant from the vegetative stage to the flowering stage rather than relying on changes in light cycles. This innovative work provides foundational insight on flowering mechanism in cannabis, which will support future breeding strategies, and can be leverage
Focused on supporting licensed cannabis retailers in New York, this collaboration highlights Leafly's dedication to supporting local, legal cannabis businesses in the Empire State Leafly (NASDAQ:LFLY), one of the world's leading cannabis discovery marketplaces and trusted educational resources, is expanding its support of the legal New York cannabis market with a new alliance with the New York Cannabis Retail Association (NYCRA), a non-profit coalition of New York dispensary owners united under the slogan ‘Collaboration Over Competition.' The partnership aims to help create a more sustainable, equitable, and inclusive cannabis industry. Together, Leafly and NYCRA will sponsor a series of
TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of
Weedmaps (NASDAQ:MAPS), a prominent online cannabis marketplace, announced a partnership with NuggMD, the leading telemedicine platform for medical cannabis patients. This collaboration aims to streamline the medical cannabis education and application process for patients through a new pilot program. Initial Phase And Target States The program seeks to improve access to medical cannabis by connecting potential patients on Weedmaps with NuggMD’s telehealth platform, according to a press release. The initial phase is active in Florida, Oklahoma, Pennsylvania, West Virginia and Louisiana, five states served by NuggMD. Patient Education And Convenience “We’re seeing more and more po
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rapidly growing German patient base. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at the company's local EU GMP facility in Leuna, Germany.
California's Glass House Reappoints Board Member As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders in the cannabis industry, let’s scroll through the latest leadership changes in the space. Get your tickets now before prices surge by following this link. Long Beach, California-based vertically-integrated cannabis company Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX:GLASF) (OTCQX:GHBWF) announced last week the reappointment of Hector De La Torre to its board of directors. De La Torre previously served as an original member of the board until 2023. At the time, he s
4 - Cronos Group Inc. (0001656472) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
Oppenheimer downgraded GrowGeneration from Outperform to Perform
Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy
Craig Hallum upgraded GrowGeneration from Hold to Buy and set a new price target of $4.75 from $4.25 previously
SC 13G/A - WM TECHNOLOGY, INC. (0001779474) (Subject)
SC 13D/A - WM TECHNOLOGY, INC. (0001779474) (Subject)
SC 13D/A - Cronos Group Inc. (0001656472) (Subject)
Focused on supporting licensed cannabis retailers in New York, this collaboration highlights Leafly's dedication to supporting local, legal cannabis businesses in the Empire State Leafly (NASDAQ:LFLY), one of the world's leading cannabis discovery marketplaces and trusted educational resources, is expanding its support of the legal New York cannabis market with a new alliance with the New York Cannabis Retail Association (NYCRA), a non-profit coalition of New York dispensary owners united under the slogan ‘Collaboration Over Competition.' The partnership aims to help create a more sustainable, equitable, and inclusive cannabis industry. Together, Leafly and NYCRA will sponsor a series of
TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of
Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline on September 20, 2024 at 1:00 p.m. (Eastern time) Company Releases Q&A About Annual Meeting Quorum Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 11, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today urges its shareholders to vote ahead of the upcoming annual general meeting of shareholders (the "Meeting") on September 24, 2024 at 1:00 pm (Eastern time). The Board of Directors of Canopy Growth recommends shareho
6-K - AURORA CANNABIS INC (0001683541) (Filer)
DEFA14A - Canopy Growth Corp (0001737927) (Filer)
DEFA14A - Canopy Growth Corp (0001737927) (Filer)
A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Aug. 23, 2024 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended June 30, 2023, unless otherwise stated. Q2 2024 Financial Highlights 12% Revenue increase to $14.8M vs. $13.2M in Q2 2023 129% increase in IMC Germany sales vs. Q2 2023 to $3.5M. IMC Germany sales now make up 24% of the entire Company r
Focus on profitable revenue generation delivered 67% increase in gross profit year-over-year Record quarter for Canada Medical Cannabis with Net Revenue increasing 20% year-over-year and 6th consecutive quarter of growth Extended maturity of senior secured term loan to December 18, 2026 with an option to further extend to September 18, 2027 SMITHS FALLS, ON, Aug. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the first quarter ended June 30, 2024 ("Q1 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.